Neurological, genetic and epigenetic features of rett syndrome

Journal of Pediatric Neurology

Volumn 2, Issue 4, 2004, Pages 179-190

  Vorsanova, Svetlana G ^a,b   Iourov, Ivan Y ^b   Yurov, Yuri B ^a,b  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Genotype phenotype correlations; MECP2 mutations; Rett syndrome; X chromosome inactivation

Indexed keywords

EID: 85013575836     PISSN: 13042580     EISSN: 13050613     Source Type: Journal    
DOI: 10.1055/s-0035-1557218     Document Type: Article

References (97)

1. Rett A. On an unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 1966; 116: 723-726 (in German).
2. Hagberg B. Rett syndrome-Clinical and Biological Aspects. Cambridge, UK: MacKeith Press, 1993.
3. Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls Rett’s syndrome: report of 35 cases. Ann Neurol 1983; 14: 471-479.
4. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein2. Nat Genet 1999; 23: 185-188.
5. Rapin I. Autism. N Engl J Med 1997; 337: 97-104.
6. Hagberg B, Hagberg G. Rett syndrome: epidemiology and geographical viability. Eur Child Adolesc Psychiatry 1997; 6 Suppl 1: 5-7.
7. Kozinetz CA, Skender ML, MacNaughton N, et al. Epidemiology of Rett syndrome: a population based registry. Pediatrics 1993; 91: 445-450.
8. Asthana JC, Sinha S, Haslam JS, Kingston HM. Survey of adolescents with severe intellectual handicap. Arch Dis Child 1990; 65: 1133-1136.
9. Leonard H, Bower C, English D. The prevalence and incidence of Rett syndrome in Australia. Eur Child Adolesc Psychiatry 1997; 6 Suppl 1: 8-10.
10. Kerr AM, Stephenson JB. A study of natural history of Rett syndrome in 23 girls. Am J Med Genet Suppl 1986; 24: 77-83.
11. Skjeldal OH, von Tetzner S, Aspelund F, Herder GA, Lofterld B. Rett syndrome: geographic variation in Norway. Brain Dev 1997; 19: 258-261.
12. Hagberg B, Berg M, Steffenburg U. Three decades of sociomedical experiences from West Swedish Rett females 4-60 years of age. Brain Dev 2001; 23 Suppl 1: S28-S31.
13. Boltshauser E, Kunzle CH. Prevalence of Rett syndrome in Switzerland. Helvetica Paed Acta 1987; 42: 407-411.
14. Vorsanova SG, Ulas VY, Demidova IA, Kravetz VS, Yurov YB. Contemporary views on Rett’s syndrome: clinical, cytogenetic and molecular studies. Zh Nevrol Psikhiatr Im S S Korsakova 1999; 99: 61-69 (in Russian).
15. Hagberg B, Witt-Engerstrom I. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet Suppl 1986; 1: 47-59.
16. Кyэrr AM, Nomura Y, Armstrong D, et al. Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev 2001; 23: 208-211.
17. Oguro N, Momoi M, Nakamigawa T, et al. Multi-institutional survey of the Rett syndrome in Japan. Brain Dev 1990; 12: 753-759.
18. Julu PO, Kerr AM, Apartopoulos F, et al. Characterization of breathing and associated central autonomic dysfunction in the Rett disorder. Arch Dis Child 2001; 85: 29-37.
19. Keret D, Bassett GS, Bunnell WP, Marks HG. Scoliosis in Rett syndrome. J Pediatr Orthop 1988; 8: 138-142.
20. Kerr AM, Armstrong DD, Prescott RJ, Doyle D, Kearney DL. Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry 1997; 6 Suppl 1: 71-74.
21. Diagnostic criteria for Rett syndrome. The Rett Syndrome Diagnostic Criteria Work Group. Ann Neurol 1988; 23: 425-428.
22. Vorsanova SG, Demidova IA, Ulas VY, Soloviev IV, Kzantseva LZ, Yurov YB. Cytogenetic and molecular-cytogenetic investigation of Rett syndrome. Analysis of 31 cases. NeuroReport 1996; 7: 187-189.
23. Hagberg B, Skjeldal OH. Rett variants: a suggested model for inclusion criteria. Pediatr Neurol 1994; 11: 5-11.
24. Zappella M. The Rett girls with preserved speech. Brain Dev 1992; 14: 98-101.
25. Goutieres F, Aicardi J. Atypical forms of Rett syndrome. Am J Med Genet Suppl 1986; 1: 183-194.
26. Colvin L, Fyfe S, Leonard S, et al. Describing the phenotype in Rett syndrome using a population database. Arch Dis Child 2003; 88: 38-43.
27. Shahbazian M, Zoghbi HY. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr Opin Neurol 2001; 14: 171-176.
28. Wahlstrom J, Anvret M. Chromosome findings in the Rett syndrome and a test of a two-step mutation theory. Am J Med Genet Suppl 1986; 1: 361-368.
29. Journel H, Melki J, Turleau C, Munnich A, de Grouchy J. Rett phenotype with X/autosome translocation: possible mapping to the short arm of chromosome X. Am J Med Genet 1990; 35: 142-147.
30. Zoghbi HY, Ledbetter DH, Schultz R, Percy AK, Glaze DG. A de novo X;3 translocation in Rett syndrome. Am J Med Genet 1990; 35: 148-151.
31. Gordon K, Siu VM, Sergovich F, Jung J. 18q-mosaicism associated with Rett syndrome phenotype. Am J Med Genet 1993; 46: 142-144.
32. Herder AG, Skjeldal O, Hagberg B. Congenital Rett syndrome phenotype - interstitial deletion chromosome 13 and retinoblastoma. Eur Child Adolesc Psychiatry 1997; 6 Suppl 1: 92.
33. Easthaugh P, Smith L, Leonard H. Trisomy 21 associated with Rett syndrome phenotype. Eur Child Adolesc Psychiatry 1997; 6 Suppl 1: 91.
34. Simonic I, Gericke GS, Lippert M, Schoeman JF. Additional clinical and cytogenetic findings associated with Rett syndrome. Am J Med Genet 1997; 31: 331-337.
35. Delobel B, Delannoy V, Pini G, et al. Identification and molecular characterization of a small 11q23.3 de novo duplication in a patient with Rett syndrome manifestations. Am J Med Genet 1998; 80: 273-280.
36. Gustavsson P, Kimber E, Wahlstrom J, Anneren G. Monosomy 18q syndrome and atypical Rett syndrome in a girl with an interstitial deletion (18)(q21.1q22.3). Am J Med Genet 1999; 82: 348-351.
37. Wahlstrom J, Uller A, Johannesson T, et al. Congenital variant Rett syndrome in a girl with terminal deletion of chromosome 3p. J Med Genet 1999; 36: 343-345.
38. Nielsen JB, Henriksen KF, Hansen C, Silahtaroğlu A, Schwartz M, Tommerup N. MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet 2001; 9: 178-184.
39. Rosenberg C, Wouters H, Szuhai K, et al. A Rett syndrome patient with a ring X chromosome: further evidence for skewing of X inactivation and heterogeneity in the aetiology of the disease. Eur J Hum Genet 2001; 9: 171-177.
40. Hammer S, Dorrani N, Hartiala J, Stein S, Schanen NC. Rett syndrome in a 47, XXX patient with a de novo MECP2 mutation. Am J Med Genet 2003; 122A: 223-226.
41. Pescucci S, Meloni I, Bruttini M, et al. Chromosome 2 deletion encompassing the MAP2 gene in a patient with autism and Rett-like features. Clin Genet 2003; 64: 497-501.
42. Panasiuk B, Midro AT, Zadrozna-Tolwinska B. Earlier finishing of Xp21.2 subband replication of the inactive X chromosome in Rett syndrome girl but not in her 47, XXX mother. Clin Genet 1997; 52: 120-125.
43. Vorsanova SG, Yurov YB, Ulas VY, et al. Cytogenetic and molecular-cytogenetic studies of Rett syndrome (RTT): a retrospective analysis of a Russian cohort of RTT patients (the investigation of 57 girls and three boys). Brain Dev 2001; 23 Suppl 1: S196-S201.
44. Vorsanova SG, Demidova IA, Ulas VY, et al. Cytogenetic and molecular genetic diagnostics of Rett syndrome in children. Zh Nevrol Psikhiatr Im S S Korsakova 1998; 98: 53-56 (in Russian).
45. Dragich J, Houwink-Manville I, Schanen C. Rett syndrome: a surprising result of mutation in MECP2. Hum Mol Genet 2000; 9: 2365-2375.
46. Gillberg C, Wahlstrom J, Hagberg B. A "new" chromosome marker common to the Rett syndrome and infantile autism? The frequency of fragile sites at X p22 in 81 children with infantile autism, childhood psychosis and the Rett syndrome. Brain Dev 1985; 7: 365-367.
47. Martinho PS, Otto PG, Kok F, Diament A, Marques-Dias MJ, Gonzalez CH. In search of a genetic basis for the Rett syndrome. Hum Genet 1990; 86: 131-134.
48. Yurov YB, Vostrikov VM, Vorsanova SG, Monakhov VV, Iourov IY. Multicolor fluorescent in situ hybridization on post mortem brain in schizophrenia as an approach for identification of low-level chromosomal aneuploidy in neuropsychiatric diseases. Brain Dev 2001; 23 Suppl 1: S186-S190.
49. Thomas GH. High male: female ratio of germ-line mutations: an alternative explanation for postulated gestational lethality in males in X-linked dominant disorders. Am J Hum Genet 1996; 58: 1364-1368.
50. Migeon BR, Dunn MA, Thomas G, Schmeckpeper BJ, Naidu S. Studies of X inactivation and isodisomy in twins provide further evidence that X chromosome is not involved in Rett syndrome. Am J Hum Genet 1995; 56: 647-653.
51. Akesson HO, Hagberg B, Wahlstrom J. Rett syndrome, classical and atypical: genealogical support for common origin. J Med Genet 1996; 33: 764-766.
52. Xiang F, Stenbom Y, Anvret M. MECP2 mutations in Swedish Rett syndrome clusters. Clin Genet 2002; 61: 384-385.
53. Sirianni N, Naidu S, Pereira J, Pilotto RF, Hoffman EP. Rett syndrome: confirmation of X-linked dominant inheritance and localization of the gene to Xq28. Am J Hum Genet 1998; 63: 1552-1558.
54. D’Esposito M, Quaderi NA, Ciccodocola A, et al. Isolation, physical mapping and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm Genome 1996; 7: 533-535.
55. Nan X, Campoy FJ, Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997; 88: 471-481.
56. Kriaucionis S, Bird A. DNA methylation and Rett syndrome. Hum Mol Genet 2003; 12: 221-227.
57. Craig JM, Earle E, Canham P, Wong LH, Anderson M, Choo KH. Analysis of mammalian proteins involved in chromatin modification reveals new metaphase centromeric proteins and distinct chromosomal distribution patterns. Hum Mol Genet 2003; 12: 3109-3121.
58. Chandler SP, Guschin D, Landsberger N, Wolffe AP. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemestry 1999; 38: 7008-7018.
59. Lunyak VV, Burgess R, Prefontaine GG, et al. Compressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 2002; 298: 1747-1752.
60. Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998; 19: 187-191.
61. Tate P, Skarnes W, Bird A. The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet 1996; 12: 205-208.
62. Balmer D, Goldstine J, Rao YM, LaSalle JM. Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J Mol Med 2003; 81: 61-68.
63. Cohen DRS, Matrazzo V, Palmer AM, et al. Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neuroscience 2003; 22: 417-429.
64. Akhmanova A, Verkerk T, Langeveld A, Grosveld F, Galjart N. Characterisation of transcriptionally active and inactive chromatin domains in neurons. J Cell Sci 2000; 113 Pt 24: 4463-4474.
65. Miltenberger-Miltenyi G, Laccone F. Mutations and polymorphisms in the human methyl CpG-binding protein MeCP2. Hum Mutat 2003; 22: 107-115.
66. Shahbazian MD, Zoghbi HY. Rett syndrome and MECP2: linking epigenetics and neuronal function. Am J Hum Genet 2002; 71: 1259-1272.
67. Auranen M, Vanhala R, Vosman M, et al. MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features. Neurology 2001; 56: 611-617.
68. Bienvenu T, Villard L, De Roux N, et al. Spectrum of MECP2 mutations in Rett syndrome. Genet Test 2002; 6: 1-6.
69. Bourdon V, Philippe C, Labrune O, Amsallem D, Arnould C, Jonveaux P. A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients. Hum Genet 2001; 108: 43-50.
70. Cheadle JP, Gill H, Fleming N, et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 2000; 9: 1119-1129.
71. Hoffbuhr K, Devaney JM, LaFleur B, et al. MECP2 mutations in children with and without the phenotype of Rett syndrome. Neurology 2001; 56: 1486-1495.
72. Vorsanova SG, Ulas VIu, Iurov IuB, et al. Genotype-phenotype correlations in Rett syndrome: the study of Russian cohort of patients. Zh Nevrol Psikhiatr Im SS Korsakova 2002; 102: 23-29 (in Russian).
73. Wan M, Lee SSJ, Zhang X. et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 1999; 65: 1520-1529.
74. Weaving LS, Williamson SL, Bennetts B, et al. Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet 2003; 118A: 103-114.
75. Xiang F, Buervenich S, Nicolao P, et al. Mutation screening in Rett syndrome patients. J Med Genet 2000; 37: 250-255.
76. Girard M, Couvert P, Carrie A, et al. Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet 2001; 9: 231-236.
77. Trappe R, Laccone F, Cobilanschi J, et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 2001; 68: 1093-1101.
78. Yusufzai TM, Wolffe AP. Functional consequences of Rett syndrome mutations on human MECP2. Nucleic Acids Res 2000; 28: 4172-4179.
79. Moog U, Smeets EE, van Roozendaal KE, et al. Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neurol 2003; 7: 5-12.
80. Watson P, Black G, Ramsden S, et al. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 2001 38: 224-228.
81. Topçu M, Akyerli C, Sayi A, et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet 2002; 10: 77-81.
82. Lynch SA, Whatley SD, Ramesh V, Sinha S, Ravine D. Sporadic case of fatal encephalopathy with neonatal onset associated with a T158M missence mutation in MECP2. Arch Dis Child 2003; 88: F250-F252.
83. Villard L, Kpebe A, Cardoso C, Chelly PJ, Tardieu PM, Fontes M. Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology 2000; 55: 1188-1193.
84. Cohen D, Lazar G, Couvert P, et al. MECP2 mutation in a boy with language disorder and schizophrenia. Am J Psychiatry 2002; 159: 148-149.
85. Couvert P, Bienvenu T, Aquaviva C, et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 2001; 10: 941-946.
86. Winnepenninckx B, Errijgers V, Hayez-Delatte F, Reyniers E, Kooy RF. Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: is there a need for routine screening? Hum Mutat 2002; 20: 249-252.
87. Klauck SM, Lindsay S, Beyer KS, Splitt M, Burn J, Poustka A. A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 2002; 70: 1034-1037.
88. Meloni I, Bruttini M, Longo I, et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 2000; 67: 982-985.
89. Zoghbi HY, Percy AK, Schultz RJ, Fill C. Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev 1990; 12: 131-135.
90. Camus P, Abbadi N, Perrier MC, Chery M, Gilgenkrantz S. X chromosome inactivation in 30 girls with Rett syndrome: analysis using the probe. Hum Genet 1996; 97: 247-250.
91. Shahbazian M, Sun Y, Zoghbi HY. Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am J Med Genet 2002; 111: 164-168.
92. Villard L, Levy N, Xiang F, et al. Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implication for the disease. J Med Genet 2001; 38: 435-442.
93. Vorsanova SG, Yurov YB, Kolotii AD, Soloviev IV. FISH analysis of replication and transcription of chromosome X loci: new approach for genetic analysis of Rett syndrome. Brain Dev 2001; 23 Suppl 1: S191-S195.
94. Yurov YB, Vorsanova SG, Kolotii AD, Iourov IY. Molecular-cytogenetic investigation of skewed chromosome X inactivation in Rett Syndrome. Brain Dev 2001; 23 Suppl 1: S214-S217.
95. Chen WG, Chang Q, Lin Y, et al. Depression of BDNF transcription involves calcium-dependent phosphorylation of MECP2. Science 2003; 302: 885-889.
96. Mnatzakanian GN, Lohi H, Munteanu I, et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 2004; 36: 339-341.
97. Schanen C, Houwink EJF, Dorrani N, et al. Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J Med Genet 2004; 126A: 129-140.